Ki-67标记指数预测非典型脑膜瘤立体定向放射外科治疗后的肿瘤进展模式与生存
回顾性研究纳入39例接受立体定向放射外科(SRS)治疗的非典型脑膜瘤患者,按Ki-67标记指数(LI)分为低(<5%)、中(5%-10%)、高(>10%)三组。中位随访26个月,高LI组3年局部肿瘤控制率、无进展率和5年疾病特异性生存率均显著低于低、中LI组,多变量分析显示高LI与不良结局显著相关。
要点
- 高Ki-67 LI(>10%)与SRS后更差的局部控制、无进展生存和疾病特异性生存显著相关。
- 3年局部肿瘤控制率:低LI组100%、中LI组74%、高LI组25%(p=0.011)。
- 3年无进展率:低LI组100%、中LI组40%、高LI组0%(p=0.003)。
核心结论
- 高Ki-67 LI患者表现出显著更多的肿瘤进展和肿瘤相关死亡。
- Ki-67 LI可能为非典型脑膜瘤SRS后的管理提供有价值的预测信息。
研究设计与样本
- 回顾性研究,纳入10年研究期间接受SRS的39例非典型脑膜瘤患者。
- 按Ki-67 LI分为低(<5%)、中(5%-10%)、高(>10%)三组。
- 评估局部肿瘤控制率、无进展率、疾病特异性生存率和不良放射诱发事件。
主要发现
- 中位随访26个月,SRS中位处方剂量18 Gy,肿瘤中位Ki-67 LI为9.6%。
- 3年局部肿瘤控制率:低LI组100% vs 中LI组74% vs 高LI组25%(p=0.011)。
- 3年无进展率:低LI组100% vs 中LI组40% vs 高LI组0%(p=0.003)。
- 5年疾病特异性生存率:低LI组100% vs 中LI组89% vs 高LI组50%(p=0.019)。
- 多变量Cox分析显示,与中LI相比,高LI与更低的局部肿瘤控制率(HR 3.92;95%CI 1.18-13.04,p=0.026)、更低的无进展率(HR 3.80;95%CI 1.46-9.88,p=0.006)和更短的疾病特异性生存(HR 6.55;95%CI 1.19-35.95,p=0.031)显著相关。
临床怎么用
- 作者认为,Ki-67 LI可能为非典型脑膜瘤SRS后的管理提供有价值的预测信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study investigated whether Ki-67 labeling index (LI) correlated with clinical outcomes after SRS for atypical meningiomas. METHODS: This retrospective study examined 39 patients with atypical meningiomas who underwent SRS over a 10-year study period. Ki-67 LI was categorized into 3 groups: low (< 5%), intermediate (5%-10%), and high (> 10%). Local tumor control rates (LCRs), progression-free rates (PFRs), disease-specific survival (DSS) rates, and adverse radiation-induced events (AREs) were evaluated. RESULTS: The median follow-up periods were 26 months. SRS was performed at a median prescription dose of 18 Gy for tumors with a median Ki-67 LI of 9.6%. The 3-year LCRs were 100%, 74%, and 25% in the low, intermediate, and high LI groups, respectively (p = 0.011). The 3-year PFRs were 100%, 40%, and 0% in the low, intermediate, and high LI groups (p = 0.003). The 5-year DSS rates were 100%, 89%, and 50% in the low, intermediate, and high LI groups (p = 0.019). Multivariable Cox proportional hazard analysis showed a significant correlation of high LI with lower LCR (hazard ratio [HR], 3.92; 95% confidence interval [CI] 1.18-13.04, p = 0.026), lower PFR (HR 3.80; 95% CI 1.46-9.88, p = 0.006), and shorter DSS (HR 6.55; 95% CI 1.19-35.95, p = 0.031) compared with intermediate LI. The ARE rates were minimal (8%) in the entire group. CONCLUSION: Patients with high Ki-67 LI showed significantly more tumor progression and tumor-related death. Ki-67 LI might offer valuable predictive insights for the post-SRS management of atypical meningiomas.
引用
- Umekawa M, Shinya Y, Hasegawa H, et al. Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery. J Neurooncol. 2024. PMID: 38369575. doi:10.1007/s11060-023-04537-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。